These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 32038614

  • 1. Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis.
    Palucci I, Maulucci G, De Maio F, Sali M, Romagnoli A, Petrone L, Fimia GM, Sanguinetti M, Goletti D, De Spirito M, Piacentini M, Delogu G.
    Front Immunol; 2019; 10():3042. PubMed ID: 32038614
    [Abstract] [Full Text] [Related]

  • 2. Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin.
    Palucci I, Salustri A, De Maio F, Pereyra Boza MDC, Paglione F, Sali M, Occhigrossi L, D'Eletto M, Rossin F, Goletti D, Sanguinetti M, Piacentini M, Delogu G.
    Int J Mol Sci; 2023 Jan 07; 24(2):. PubMed ID: 36674717
    [Abstract] [Full Text] [Related]

  • 3. Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.
    Palucci I, Matic I, Falasca L, Minerva M, Maulucci G, De Spirito M, Petruccioli E, Goletti D, Rossin F, Piacentini M, Delogu G.
    J Intern Med; 2018 Mar 07; 283(3):303-313. PubMed ID: 29205566
    [Abstract] [Full Text] [Related]

  • 4. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant Mycobacterium tuberculosis Strains.
    Lyu XL, Lin TT, Gao JT, Jia HY, Zhu CZ, Li ZH, Dong J, Sun Q, Shu W, Pan LP, Zhang ZD, Li Q.
    Front Immunol; 2021 Mar 07; 12():796677. PubMed ID: 35003120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
    Hawn TR, Shah JA, Kalman D.
    Immunol Rev; 2015 Mar 07; 264(1):344-62. PubMed ID: 25703571
    [Abstract] [Full Text] [Related]

  • 10. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D, Podell BK, Chambers M, Basaraba RJ.
    Semin Immunopathol; 2016 Mar 07; 38(2):167-83. PubMed ID: 26510950
    [Abstract] [Full Text] [Related]

  • 11. Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo.
    Jeitner TM, Pinto JT, Cooper AJL.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30054429
    [Abstract] [Full Text] [Related]

  • 12. Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease.
    Palucci I, Delogu G.
    Chemotherapy; 2018 Oct 31; 63(3):172-180. PubMed ID: 30032143
    [Abstract] [Full Text] [Related]

  • 13. Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism.
    Palanski BA, Khosla C.
    Biochemistry; 2018 Jun 19; 57(24):3359-3363. PubMed ID: 29570977
    [Abstract] [Full Text] [Related]

  • 14. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances in vitro and in vivo Anti-mycobacterial Activity in Human Macrophages and in Zebrafish.
    Moreira JD, Koch BEV, van Veen S, Walburg KV, Vrieling F, Mara Pinto Dabés Guimarães T, Meijer AH, Spaink HP, Ottenhoff THM, Haks MC, Heemskerk MT.
    Front Immunol; 2020 Jun 19; 11():36. PubMed ID: 32117228
    [Abstract] [Full Text] [Related]

  • 15. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of Mycobacterium tuberculosis through induction of autophagy and augment anti-TB activity of isoniazid in RAW 264.7 macrophages.
    Gupta PK, Jahagirdar P, Tripathi D, Devarajan PV, Kulkarni S.
    Front Immunol; 2023 Jun 19; 14():1233630. PubMed ID: 37583694
    [Abstract] [Full Text] [Related]

  • 16. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R, Heemskerk MT, Forn-Cuní G, Korbee CJ, Walburg KV, Esselink JJ, Carvalho Dos Santos C, de Waal AM, van der Hoeven DCM, van der Sar E, de Ries AS, Xie J, Spaink HP, van der Vaart M, Haks MC, Meijer AH, Ottenhoff THM.
    mBio; 2023 Feb 28; 14(1):e0302422. PubMed ID: 36475748
    [Abstract] [Full Text] [Related]

  • 17. The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with Mycobacterium tuberculosis.
    Cahill C, Cox DJ, O'Connell F, Basdeo SA, Gogan KM, Ó'Maoldomhnaigh C, O'Sullivan J, Keane J, Phelan JJ.
    Int J Mol Sci; 2021 Nov 10; 22(22):. PubMed ID: 34830070
    [Abstract] [Full Text] [Related]

  • 18. Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy.
    Kilinç G, Boland R, Heemskerk MT, Spaink HP, Haks MC, van der Vaart M, Ottenhoff THM, Meijer AH, Saris A.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0016724. PubMed ID: 38916320
    [Abstract] [Full Text] [Related]

  • 19. Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy.
    Pi J, Chen D, Wang J, Yang E, Yang J, Liu Y, Yu J, Xia J, Huang X, Chen L, Ruan Y, Xu JF, Yang F, Shen L.
    Pharmacol Res; 2024 Oct 06; 208():107379. PubMed ID: 39218421
    [Abstract] [Full Text] [Related]

  • 20. Marine-Fungi-Derived Gliotoxin Promotes Autophagy to Suppress Mycobacteria tuberculosis Infection in Macrophage.
    Fu J, Luo X, Lin M, Xiao Z, Huang L, Wang J, Zhu Y, Liu Y, Tao H.
    Mar Drugs; 2023 Nov 28; 21(12):. PubMed ID: 38132937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.